GLP1 receptor agonists exhibit antioxidant and anti-inflammatory properties in human heart tissue via the canonical GLP1 receptor expression through a AMPK-mediated pathway
Event: ESC Congress 2023
Topic: Antidiabetic Pharmacotherapy
Session: Novel targets and treatments for heart diseases and diabetes
